Furthermore, the functional study confirmed that the overexpression of HCLS1, EVI2B, and CD48 can reduce the proliferation, migration and invasion ability of CRC cells in vitro and significantly suppress CRC tumor growth in vivo. This evidence concerns the gene CD48 and neoplasm.